Clinical Trials Directory

Trials / Completed

CompletedNCT00164840

Symptomatic Gastroesophageal Reflux Disease: Double Blind Randomized Controlled Study of On-demand Therapy Versus Maintenance Therapy

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
244 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Maintenance treatment with proton pump inhibitor (PPI) is the most widely recommended modality of treatment for long-term management of gastroesophageal reflux disease (GERD). Yet in clinical practice treatment is commonly given in short courses on as required basis during symptom flare up, particularly for patients with mild to moderate GERD. On-demand therapy also has the potential advantage that patient does not need to take regular medications, thereby improving the quality of life. However, whether on-demand PPI therapy achieves similar efficacy of symptom control is uncertain. The aim of this study is to compare the efficacy and quality of life of on-demand and maintenance PPI regimens in long-term management of non-erosive GERD patients. The investigators hypothesize that on-demand PPI treatment is as effective as maintenance PPI.

Conditions

Interventions

TypeNameDescription
DRUGEsomeprazole

Timeline

Start date
2003-05-01
Primary completion
2008-11-01
Completion
2008-11-01
First posted
2005-09-14
Last updated
2010-03-30

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT00164840. Inclusion in this directory is not an endorsement.